The HTRA1 Gene CARASIL Genetic Test is a specialized diagnostic procedure designed to identify mutations in the HTRA1 gene, which are associated with Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL). CARASIL is a rare genetic disorder that affects the brain's small blood vessels, leading to a range of neurological symptoms, including stroke, cognitive decline, and walking difficulties. The test is crucial for individuals with a family history of CARASIL or those exhibiting symptoms, as early detection can aid in managing the condition and understanding the risk for family members.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability of results. The cost of the HTRA1 Gene CARASIL Genetic Test at DNA Labs UAE is set at 4400 AED, reflecting the sophisticated technology and expertise involved in conducting the genetic analysis. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for informed medical decisions and personalized care plans.
The "PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test" is a specialized diagnostic tool designed to assess the risk associated with carotid artery disease by examining the PPARG gene. The PPARG (Peroxisome Proliferator-Activated Receptor Gamma) gene plays a crucial role in the regulation of fatty acid storage and glucose metabolism, which are key factors in the development of atherosclerosis, leading to increased carotid intimal medial thickness (CIMT). An increased CIMT is a significant predictor of cardiovascular events, including stroke and heart attack.
This genetic test, available at DNA Labs UAE for a cost of 4400 AED, involves a non-invasive procedure that requires a simple blood sample from the patient. The analysis focuses on identifying specific mutations or variations in the PPARG gene that may contribute to the increased risk of developing thicker carotid artery walls, which can impede blood flow and lead to serious cardiovascular conditions. The test results can provide valuable information for both patients and healthcare providers, enabling them to understand genetic predispositions and potentially tailor prevention strategies or treatments to manage or mitigate the risk of carotid artery disease and its complications.
The KRIT1 Gene Cerebral Cavernous Malformations Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the KRIT1 gene. These mutations are responsible for Type 1 Cerebral Cavernous Malformations (CCM1), a condition characterized by the formation of abnormal blood vessels in the brain and spinal cord, which can lead to various neurological symptoms. The test is crucial for individuals with a family history of CCM1 or those exhibiting symptoms suggestive of the condition, as it helps in confirming the diagnosis, guiding treatment decisions, and assessing the risk for family members. The cost of the test is set at 4400 AED, reflecting the advanced genetic analysis involved in identifying the presence of mutations in the KRIT1 gene accurately. By opting for this test at DNA Labs UAE, patients and healthcare providers can access vital genetic information that plays a significant role in the management and understanding of Cerebral Cavernous Malformations.
The "CCM2 Gene Cerebral Cavernous Malformations Type 2 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the CCM2 gene, which are associated with Cerebral Cavernous Malformations (CCM) Type 2. CCMs are vascular disorders characterized by clusters of dilated blood vessels in the brain, which can lead to various neurological symptoms, including seizures, headaches, and in severe cases, hemorrhagic stroke. The test is crucial for individuals with a family history of CCM or those exhibiting symptoms suggestive of the condition, as it helps in confirming the diagnosis, guiding treatment options, and assessing the risk of transmission to offspring. Priced at 4400 AED, this genetic test offers a comprehensive analysis, providing valuable insights for affected individuals and their families regarding the management and potential implications of this condition.
The PDCD10 Gene Cerebral Cavernous Malformations Type 3 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the PDCD10 gene, which are associated with Cerebral Cavernous Malformations Type 3 (CCM3). Cerebral cavernous malformations are vascular disorders characterized by clusters of dilated blood vessels in the brain, which can lead to various neurological symptoms such as seizures, headaches, and potentially serious bleeding in the brain. The PDCD10 gene plays a crucial role in the development and maintenance of cardiovascular integrity, and mutations in this gene can disrupt the function of blood vessels, leading to the formation of cavernous malformations.
The test is conducted through a detailed analysis of the individual's DNA, typically obtained via a blood sample, to identify any genetic mutations in the PDCD10 gene. This genetic test is vital for individuals with a family history of Cerebral Cavernous Malformations or those who have been diagnosed with the condition, as it can provide valuable information for managing the disease and making informed decisions about treatment options.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test not only aids in the confirmation of a CCM3 diagnosis but also helps in assessing the risk of developing the condition for family members of affected individuals. Given the potential severity of CCM3, early detection through genetic testing is crucial for timely intervention and management of the condition.
The MCTP2 gene coarctation of the aorta genetic test is a specialized diagnostic procedure aimed at identifying mutations in the MCTP2 gene, which have been associated with the development of coarctation of the aorta (CoA). CoA is a congenital condition characterized by the narrowing of the aorta, which can lead to various cardiovascular complications. This test is crucial for individuals who have a family history of CoA or exhibit symptoms related to this condition, as early detection can significantly improve management and treatment outcomes.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The laboratory employs advanced genetic sequencing technologies to analyze the MCTP2 gene for any mutations that could predispose an individual to CoA. The results from this test can provide valuable information for personalized treatment plans, risk assessment for family members, and informed decision-making regarding health and lifestyle adjustments.
The cost of the MCTP2 gene coarctation of the aorta genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the insights gained from this test can be invaluable for individuals at risk, offering a proactive approach to managing and potentially mitigating the impacts of coarctation of the aorta.
The ABCA1 gene plays a crucial role in lipid metabolism by regulating cholesterol efflux from cells to apolipoproteins, a process fundamental in preventing the buildup of cholesterol and thus reducing the risk of coronary artery disease (CAD). Familial Hypercholesterolemia (FH) is a genetic condition characterized by elevated cholesterol levels, leading to an increased risk of coronary artery disease. Interestingly, variations within the ABCA1 gene have been associated with a protective effect against the development of CAD in individuals with FH.
DNA Labs UAE offers a genetic test specifically designed to analyze the ABCA1 gene to identify protective variants that may reduce the risk of coronary artery disease in individuals with familial hypercholesterolemia. This test is particularly valuable for individuals with a family history of FH or early-onset CAD, providing crucial information for personalized risk assessment and management strategies.
The cost of the ABCA1 Gene Coronary Artery Disease Protection Test is 4400 AED. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves a simple blood draw or cheek swab, followed by sophisticated genetic analysis to identify the presence of protective ABCA1 gene variants. The results from this test can offer significant insights for individuals and families affected by FH, aiding in the development of targeted interventions to reduce the risk of CAD.
The GLA Gene Fabry Disease Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GLA gene, which is known to cause Fabry disease. Fabry disease is a rare genetic disorder that affects many parts of the body including the skin, eyes, kidneys, heart, and nervous system. It is categorized under lysosomal storage disorders and is caused by the buildup of a type of fat called globotriaosylceramide due to insufficient activity of the enzyme alpha-galactosidase A, encoded by the GLA gene.
This genetic test is crucial for the early detection and management of Fabry disease, enabling healthcare providers to devise appropriate treatment and management plans for affected individuals. The test involves analyzing the patient's DNA, extracted from a blood sample, to look for mutations in the GLA gene that are indicative of the disease.
DNA Labs UAE offers this test at a cost of 3200 AED. Conducted in a state-of-the-art facility with advanced genetic testing technologies, the GLA Gene Fabry Disease Genetic Test by DNA Labs UAE is a valuable tool for individuals with a family history of Fabry disease or those exhibiting symptoms related to the disorder, facilitating early intervention and better health outcomes.
The F2 Gene Factor II Deficiency Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the F2 gene, which can lead to Factor II deficiency. This condition, also known as Prothrombin deficiency, is a rare blood clotting disorder that increases the risk of excessive bleeding or thrombosis. The test is crucial for individuals with a family history of the disorder or those experiencing symptoms related to abnormal clotting. By analyzing a small sample of the patient's DNA, the test can pinpoint specific genetic mutations responsible for the condition, enabling healthcare providers to devise appropriate management or treatment plans. The cost of the test is set at 4400 AED, reflecting the intricate technology and expert analysis involved in identifying the genetic underpinnings of Factor II deficiency.
The F7 Gene Factor VII Deficiency Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the F7 gene, which are responsible for Factor VII deficiency. This condition is a rare coagulation disorder that can lead to increased bleeding or clotting times, posing significant health risks. The test is essential for individuals with a family history of the disorder or those exhibiting symptoms, as early detection can lead to better management and treatment options.
The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the F7 gene. The accuracy and reliability of the test make it a crucial step in diagnosing Factor VII deficiency, allowing for personalized treatment plans to be developed.
Priced at 4400 AED, the test is an investment in personal health, offering invaluable insights into one's genetic predisposition towards Factor VII deficiency. Conducted in the state-of-the-art facilities of DNA Labs UAE, clients are assured of a professional and supportive experience, guided by experts in genetic testing. This test not only aids in diagnosis but also plays a vital role in preventive health care, enabling individuals to take proactive steps towards managing their health.
